Becton, Dickinson and Company (BDX)

NYSE: BDX · Real-Time Price · USD
185.32
+1.69 (0.92%)
At close: Jul 25, 2025, 4:00 PM
186.00
+0.68 (0.37%)
After-hours: Jul 25, 2025, 7:50 PM EDT
0.92%
Market Cap53.11B
Revenue (ttm)20.87B
Net Income (ttm)1.50B
Shares Out 286.61M
EPS (ttm)5.16
PE Ratio35.90
Forward PE13.10
Dividend$4.16 (2.24%)
Ex-Dividend DateSep 8, 2025
Volume1,875,314
Open184.35
Previous Close183.63
Day's Range183.42 - 185.92
52-Week Range163.33 - 251.99
Beta0.28
AnalystsBuy
Price Target231.50 (+24.92%)
Earnings DateAug 7, 2025

About BDX

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system... [Read more]

Sector Healthcare
IPO Date Apr 23, 1962
Employees 73,000
Stock Exchange NYSE
Ticker Symbol BDX
Full Company Profile

Financial Performance

In 2024, BDX's revenue was $20.18 billion, an increase of 4.16% compared to the previous year's $19.37 billion. Earnings were $1.71 billion, an increase of 19.73%.

Financial Statements

Analyst Summary

According to 9 analysts, the average rating for BDX stock is "Buy." The 12-month stock price target is $231.5, which is an increase of 24.92% from the latest price.

Price Target
$231.5
(24.92% upside)
Analyst Consensus: Buy
Stock Forecasts

News

BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs

FRANKLIN LAKES, N.J. , July 23, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination produ...

3 days ago - PRNewsWire

BD Board Declares Dividend

FRANKLIN LAKES, N.J. , July 22, 2025 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has decla...

3 days ago - PRNewsWire

Best Dividend Kings: July 2025

14 Dividend Kings continue to outperform the S&P 500 in 2025. Dividend growth remains healthy, with one recent increase and a collective 2025 growth rate of 5.23%. Seventeen Dividend Kings currently a...

Other symbols: ABBVABMABTADMADPAWRBKH
3 days ago - Seeking Alpha

WATERS CORPORATION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Waters Corporation - WAT

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger o...

Other symbols: WAT
9 days ago - Business Wire

Becton Dickinson gets its spinoff deal, but the stock is still falling

Becton Dickinson will spin off its biosciences and diagnostic business and merge it with Waters, and plans to use at least $2 billion of the proceeds to buy back stock.

11 days ago - Market Watch

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...

Other symbols: WAT
12 days ago - PRNewsWire

BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment

FRANKLIN LAKES, N.J. , July 7, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that, effective July 2, Bilal Muhsin ha...

18 days ago - PRNewsWire

Best Dividend Aristocrats For July 2025

Dividend Aristocrats have underperformed the S&P 500 in 2025, with NOBL up 1.77% versus SPY's 5.55% year-to-date gain. Dividend growth remains healthy, with 44 out of 69 Aristocrats already raising pa...

26 days ago - Seeking Alpha

New vaccine panel meeting underway

CNBC's Angelica Peebles joins 'Squawk on the Street' to discuss the latest news on vaccines.

Other symbols: BMYMRKUNHZBH
4 weeks ago - CNBC Television

Becton Dickinson Stock (BDX): Why It's Best To Avoid For Now

Shares of Becton Dickinson and Company BDX are currently in its 17th phase of the 18-phase Adhishthana Cycle, and signs point toward continued underperformance and consolidation, likely lasting until ...

4 weeks ago - Benzinga

Best Dividend Kings: June 2025

Dividend Kings have underperformed the S&P 500 year-to-date, but 26 are outperforming SPY in 2025, with 32 posting positive returns. Dividend growth remains healthy, with four recent increases and a c...

Other symbols: ABTADMBKHEDEMRFTSFUL
4 weeks ago - Seeking Alpha

Becton, Dickinson and Company (BDX) Presents at Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)

Becton, Dickinson and Company (NYSE:BDX) Goldman Sachs 46th Annual Global Healthcare Conference June 9, 2025 2:00 PM ET Company Participants Thomas E. Polen - President, CEO & Chairman Conference Cal...

6 weeks ago - Seeking Alpha

Becton, Dickinson: A Dividend King Facing Challenges Offers Value

Becton, Dickinson is significantly undervalued, trading at 12.3x earnings with a 2.5% dividend yield, the highest in a decade. The company boasts a 53-year streak of dividend growth, excellent dividen...

6 weeks ago - Seeking Alpha

June's Top Dividend Aristocrat Fat Pitches: Blue-Chip Bargains You Can't Miss

Despite bubble fears, 91% of market gains since 2009 are justified by fundamentals like earnings, dividends, and strong balance sheets. Stocks appear overvalued at face value, but strong long-term ear...

Other symbols: FRTNVONWNSON
7 weeks ago - Seeking Alpha

June's Dividend Kings: 3 Ideal Buys In 25 "Safer" Dogs

Most Dividend Kings are currently overpriced, but six offer fair value where annual dividends from $1,000 invested exceed their share price. Three top-yield Dividend Kings—Altria, Northwest Natural, a...

Other symbols: ABBVABMADMADPBKHCWTFRT
7 weeks ago - Seeking Alpha

BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease

FRANKLIN LAKES, N.J. , May 28, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to initiate a patient data regist...

2 months ago - PRNewsWire

Best Dividend Aristocrats For June 2025

Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 20...

2 months ago - Seeking Alpha

BD to Present at Goldman Sachs 46th Annual Global Healthcare Conference

FRANKLIN LAKES, N.J. , May 27, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the Goldman Sac...

2 months ago - PRNewsWire

Cancer Patients Face Elevated Risk of Carrying Antimicrobial Resistant 'Superbugs'

FRANKLIN LAKES, N.J. , May 21, 2025 /PRNewswire/ -- First-of-their-kind studies published in The Lancet Oncology 1 and Cancer Medicine 2 provide new data showing that cancer patients in both hospital ...

2 months ago - PRNewsWire

35 Barron's Pro-Picks: One Ideal May DiviDog

Barron's interviewed eleven financial industry Roundtable-pros who tapped 65 predictions. Six non-ADR foreign-stocks and four mutual funds were dropped by YCharts screens of active US listings, leavin...

2 months ago - Seeking Alpha

Becton, Dickinson and Company (BDX) Bank of America Securities Health Care Conference - (Transcript)

Becton, Dickinson and Company (NYSE:BDX) Bank of America Securities Health Care Conference Call May 13, 2025 1:00 PM ET Company Participants Tom Polen - Chairman, Chief Executive Officer and Presiden...

2 months ago - Seeking Alpha

BD to Announce Financial Results for its Third Quarter of Fiscal 2025

FRANKLIN LAKES, N.J. , May 12, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio w...

2 months ago - PRNewsWire

The Best Health Care Stocks to Buy

The best health care stocks offer investors a defensive hedge in an uncertain market. Here's how to find them.

Other symbols: CISEM
2 months ago - Kiplinger

Buy 3 "Safer" Dividend Kings Of 25 From May's 55

The May collection of Dividend Kings grew to 55, with Automatic Data Processing and RLI Corporation joining, despite two companies dropping off for not increasing dividends. Six top-yield Dividend Kin...

Other symbols: ADMADPBKHCWTEDFRTFTS
2 months ago - Seeking Alpha

Becton Dickinson Vitals Drop: Analysts 'Have Been Wrong' On This Med Tech Stock For Years

Becton Dickinson, and Company BDX lowered its fiscal year 2025 guidance and provided an estimated tariff impact on Thursday.

3 months ago - Benzinga